期刊论文详细信息
Harm Reduction Journal | |
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation | |
Research | |
Mehri S. McKellar1  Yujung Choi2  Brian Perry2  Hillary Chen2  Andrea Des Marais2  Amy Corneli3  Nidhi Sachdeva4  Christina S. Meade5  Jesse Bennett6  Rebecca Lilly7  Lauren Kestner8  Denae Ayers8  | |
[1] Department of Medicine, Duke University School of Medicine, Durham, NC, USA;Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St, 27701, Durham, NC, USA;Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St, 27701, Durham, NC, USA;Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA;Department of Medicine, Duke University School of Medicine, Durham, NC, USA;Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St, 27701, Durham, NC, USA;North Carolina Association of County Commissioners, Raleigh, NC, USA;Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA;North Carolina Harm Reduction Coalition, Wilmington, NC, USA;North Carolina Harm Reduction Coalition, Wilmington, NC, USA;Port City Harm Reduction, Wilmington, NC, USA;Queen City Harm Reduction, Charlotte, NC, USA; | |
关键词: Pre-exposure prophylaxis; HIV prevention; People who inject drugs; Medication for opioid use disorder; Telemedicine; Syringe services programs; | |
DOI : 10.1186/s12954-022-00718-1 | |
received in 2022-09-08, accepted in 2022-11-19, 发布年份 2022 | |
来源: Springer | |
【 授权许可】
CC BY
© The Author(s) 2022
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202305066950780ZK.pdf | 959KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
- [50]
- [51]
- [52]
- [53]
- [54]
- [55]
- [56]
- [57]
- [58]